Mesenchymal stromal cell-derived extracellular vesicle therapy prevents preeclamptic physiology through intrauterine immunomodulation(†)

Human umbilical cord-derived mesenchymal stromal cells (MSCs) are a widely recognized treatment modality for a variety of preclinical disease models and have been transitioned to human clinical trials. We have previously shown in neonatal lung disease that the therapeutic capacity of MSCs is conferr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biol Reprod
Autors principals: Taglauer, Elizabeth S, Fernandez-Gonzalez, Angeles, Willis, Gareth R, Reis, Monica, Yeung, Vincent, Liu, Xianlan, Mitsialis, S Alex, Kourembanas, Stella
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7876668/
https://ncbi.nlm.nih.gov/pubmed/33112369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/biolre/ioaa198
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars